MSRPS
SAGE

Maryland State Retirement & Pension System’s Sage Therapeutics SAGE Stock Holding History

Maryland State Retirement & Pension System’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,868
Closed -$211K – 1517
2021
Q2 		$211K Hold
3,868
– – 0.01% 923
2021
Q1 		$290K Buy
+3,868
New +$317K 0.01% 898

Other funds holding SAGE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Maryland State Retirement & Pension System's SAGE Position: Q3 2021 in Review

Maryland State Retirement & Pension System sold out of Sage Therapeutics (SAGE) in Q3 2021, closing a stake of 3,868 shares — an estimated $211K sold.

Maryland State Retirement & Pension System first reported a position in SAGE in Q1 2021 and held it in 2 quarters. The position peaked at $290K in Q1 2021. 225 funds tracked by Wall St. Rank hold SAGE as of Q3 2021.

  • Maryland State Retirement & Pension System reported no remaining Sage Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Maryland State Retirement & Pension System sold 3,868 Sage Therapeutics shares in Q3 2021, an estimated $211K.
  • Maryland State Retirement & Pension System first reported a position in Sage Therapeutics in Q1 2021 and held it in 2 quarters.
  • Maryland State Retirement & Pension System's Sage Therapeutics position peaked at $290K in Q1 2021.
  • 225 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2021.

Based on Maryland State Retirement & Pension System's 13F filing for Q3 2021, filed 29 Oct 2021.